302 related articles for article (PubMed ID: 27526711)
21. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
22. IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: ex vivo selective depletion of host-reactive T cells and in vivo therapy.
Yarkoni S; Prigozhina TB; Slavin S; Askenasy N
Biol Blood Marrow Transplant; 2012 Apr; 18(4):523-35. PubMed ID: 22227590
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells.
Coenen JJ; Koenen HJ; van Rijssen E; Kasran A; Boon L; Hilbrands LB; Joosten I
Bone Marrow Transplant; 2007 May; 39(9):537-45. PubMed ID: 17351648
[TBL] [Abstract][Full Text] [Related]
24. Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity.
Vaeth M; Bäuerlein CA; Pusch T; Findeis J; Chopra M; Mottok A; Rosenwald A; Beilhack A; Berberich-Siebelt F
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1125-30. PubMed ID: 25583478
[TBL] [Abstract][Full Text] [Related]
25. Insights into the pathogenesis of GvHD: what mice can teach us about man.
Hülsdünker J; Zeiser R
Tissue Antigens; 2015 Jan; 85(1):2-9. PubMed ID: 25532439
[TBL] [Abstract][Full Text] [Related]
26. TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation.
Mancusi A; Alvarez M; Piccinelli S; Velardi A; Pierini A
Cytokine Growth Factor Rev; 2019 Jun; 47():54-61. PubMed ID: 31122819
[TBL] [Abstract][Full Text] [Related]
27. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
Karakhanova S; Munder M; Schneider M; Bonyhadi M; Ho AD; Goerner M
J Immunother; 2006; 29(3):336-49. PubMed ID: 16699377
[TBL] [Abstract][Full Text] [Related]
28. [Effect of donor CD4+CD25+ regulatory T cells on hematopoietic and immune reconstitution, GVHD and disease-free survival after allogeneic hematopoietic stem cell transplantation].
Yang K; Fan ZP; Liu QF; Zhang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):537-41. PubMed ID: 18495584
[TBL] [Abstract][Full Text] [Related]
29. Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice.
Sela U; Olds P; Park A; Schlesinger SJ; Steinman RM
J Exp Med; 2011 Nov; 208(12):2489-96. PubMed ID: 22084406
[TBL] [Abstract][Full Text] [Related]
30. Azacitidine Mitigates Graft-versus-Host Disease via Differential Effects on the Proliferation of T Effectors and Natural Regulatory T Cells In Vivo.
Cooper ML; Choi J; Karpova D; Vij K; Ritchey J; Schroeder MA; DiPersio JF
J Immunol; 2017 May; 198(9):3746-3754. PubMed ID: 28330901
[TBL] [Abstract][Full Text] [Related]
31. PD-1 and CTLA-4 up regulation on donor T cells is insufficient to prevent GvHD in allo-HSCT recipients.
Hossain MS; Kunter GM; El-Najjar VF; Jaye DL; Al-Kadhimi Z; Taofeek OK; Li JM; Waller EK
PLoS One; 2017; 12(9):e0184254. PubMed ID: 28953925
[TBL] [Abstract][Full Text] [Related]
32. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD.
Sofi MH; Wu Y; Ticer T; Schutt S; Bastian D; Choi HJ; Tian L; Mealer C; Liu C; Westwater C; Armeson KE; Alekseyenko AV; Yu XZ
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554953
[TBL] [Abstract][Full Text] [Related]
33. Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice.
Zheng J; Liu Y; Liu Y; Liu M; Xiang Z; Lam KT; Lewis DB; Lau YL; Tu W
Sci Transl Med; 2013 Jan; 5(168):168ra9. PubMed ID: 23325802
[TBL] [Abstract][Full Text] [Related]
34. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation.
Asavaroengchai W; Wang H; Wang S; Wang L; Bronson R; Sykes M; Yang YG
Biol Blood Marrow Transplant; 2007 Jan; 13(1):46-55. PubMed ID: 17222752
[TBL] [Abstract][Full Text] [Related]
35. Tolerance induction between two different strains of parental mice prevents graft-versus-host disease in haploidentical hematopoietic stem cell transplantation to F1 mice.
Guo Y; Zhang L; Wan S; Sun X; Wu Y; Yu XZ; Xia CQ
Biochem Biophys Res Commun; 2014 Apr; 446(4):1035-41. PubMed ID: 24661874
[TBL] [Abstract][Full Text] [Related]
36. Increased Foxp3
Chen YB; Efebera YA; Johnston L; Ball ED; Avigan D; Lekakis LJ; Bachier CR; Martin P; Duramad O; Ishii Y; Han S; Jung YJ; Lee D; Kunkel L; Negrin RS; Bui JD
Biol Blood Marrow Transplant; 2017 Apr; 23(4):625-634. PubMed ID: 28104514
[TBL] [Abstract][Full Text] [Related]
37. [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
Liu YJ; Wu DP; Li CX; He J; Qiu QC; Zhang XG
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):835-8. PubMed ID: 17217750
[TBL] [Abstract][Full Text] [Related]
38. HY-Specific Induced Regulatory T Cells Display High Specificity and Efficacy in the Prevention of Acute Graft-versus-Host Disease.
Li J; Heinrichs J; Haarberg K; Semple K; Veerapathran A; Liu C; Anasetti C; Yu XZ
J Immunol; 2015 Jul; 195(2):717-25. PubMed ID: 26048147
[TBL] [Abstract][Full Text] [Related]
39. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.
Edinger M; Hoffmann P; Ermann J; Drago K; Fathman CG; Strober S; Negrin RS
Nat Med; 2003 Sep; 9(9):1144-50. PubMed ID: 12925844
[TBL] [Abstract][Full Text] [Related]
40. Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation.
Wolf D; Wolf AM; Fong D; Rumpold H; Strasak A; Clausen J; Nachbaur D
Transplantation; 2007 Apr; 83(8):1107-13. PubMed ID: 17452902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]